Document Detail

Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke-prone spontaneously hypertensive rats.
MedLine Citation:
PMID:  1971305     Owner:  NLM     Status:  MEDLINE    
The preventive effects of carteolol, a beta-adrenoceptor antagonist, on secondary lesions were pathophysiologically examined in stroke-prone spontaneously hypertensive rats (SHRSP) from 8 to 30 weeks of age. Carteolol was added to the drinking water in doses of 0.005% (8 to 18 weeks of age) to 0.01% (19 to 30 weeks of age) (3.8 and 6.0 mg/kg/d, respectively). These animals gained significantly more weight than the untreated control SHRSP, and their heart rate reduced from 14 weeks of age. Suppression of blood pressure rise was not definite, however, histology revealed prevention of the development or aggravation of secondary hypertension-related lesions, such as myocardial fibrosis, proliferative arteriolitis, necrotic arteriolitis and renal glomerular lesions. A decrease in non-esterified fatty acids in the serum was evident. Thus, carteolol has cardiac as well as renal protective effects, in the SHRSP.
K Yamashita; H Ohta; S Uchida; K Shigematsu; T Ohkubo; M Niwa; M Ozaki
Related Documents :
6327525 - Effect of ouabain on arteriolar responses to norepinephrine in chronic, benign, volume-...
15587405 - Tetrandrine ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in...
25286225 - Noradrenergic influences in the basolateral amygdala on inhibitory avoidance memory are...
4002975 - Acute portal vein stenosis. an experimental study on portal circulation and hepatosplen...
21527345 - Melatonin independent protective role of l-tryptophan in experimental reflux esophagiti...
6408155 - Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pharmacobio-dynamics     Volume:  13     ISSN:  0386-846X     ISO Abbreviation:  J. Pharmacobio-dyn.     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-06-28     Completed Date:  1990-06-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7901854     Medline TA:  J Pharmacobiodyn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  64-9     Citation Subset:  IM    
Department of Pharmacology 2, Nagasaki University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Glands / pathology
Adrenergic beta-Antagonists / pharmacology
Aorta, Abdominal / pathology
Blood Pressure / drug effects*
Blood Urea Nitrogen
Body Weight / drug effects
Brain / pathology
Carteolol / pharmacology*
Fatty Acids, Nonesterified / blood
Heart Rate / drug effects
Kidney / pathology
Liver / pathology
Lung / pathology
Mesentery / pathology
Myocardium / pathology
Organ Size / drug effects
Propanolamines / pharmacology*
Rats, Inbred SHR
Rats, Inbred WKY
Spleen / pathology
Triglycerides / blood
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Fatty Acids, Nonesterified; 0/Propanolamines; 0/Triglycerides; 51781-06-7/Carteolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of beta-adrenergic blockade in acute myocardial infarction: evaluation by radionuclide ventr...
Next Document:  Synthesis of valproyl-2-pyrrolidinone and its evaluation as a cognitive drug with the ability to mod...